Weekly funding picks, June 1–7: battery project finance, cell reprogramming and GPU debt
encosa separates equity for its team from debt for battery assets; NewLimit targets human trials; Duos finances 2,304 GPUs.
encosa announced €25 million in combined financing on June 1, including equity led by Realyze Ventures and a scalable debt facility. The split between the instruments was not disclosed.
Equity will support hiring, project delivery and technology development; debt will expand the battery portfolio. encosa plans, finances, installs and operates systems for commercial and industrial customers, combining energy-use optimisation with power trading.
NewLimit plans its first human trial for 2027
NewLimit closed a $435 million Series C announced June 2, led by Founders Fund. Thrive Capital, Greenoaks and Quiet Capital joined as new investors.
The company will advance medicines intended to restore function in ageing cells through epigenetic reprogramming. Its first planned human trial, focused on liver cells, was scheduled for 2027 at the announcement. AI and genomics tools support a broader pipeline spanning metabolic, vascular and immune health.
Duos Edge AI borrows against GPU infrastructure
USD.AI announced a $98.1 million, three-year debt facility on June 5 to support deployment of 2,304 NVIDIA B300 GPUs operated by Duos Edge AI. Hydra Host will manage the GPU services and workload operations.
The non-recourse financing is secured by the GPU infrastructure and associated offtake contracts. The structure pairs physical deployment and compute services with debt backed by the assets.
The selected financings
Sources
All rounds in this edition
| Company | Amount | Round | Sector · country | Investors | Date |
|---|---|---|---|---|---|
| SignalPlus Provides institutional digital assets options and derivatives trading infrastructure | $50M | Series B1 | Fintech · China | BlockBooster, HashKey Capital, AppWorks, Tencent | |
| Waypoint Bio Develops AI-designed CAR T therapies for solid tumors using spatial biology | $20M | Series A | Biotech · United States | Amplify Partners, Lux Capital, Time BioVentures, General Catalyst, Mitsui Global Investments, Hummingbird Ventures | |
| KorinMi KorinMi operates Korean-style skin and hair clinics and sells skincare products in India. | ₹100M | Funding round | Consumer · India | Lotus Innovation Fund (lead) | |
| ANY (Rise Global BV) ANY develops modular electric vehicles combining two-wheeler mobility with practical cargo space. | €1.2M | Cash equity subscription | Mobility · Belgium | ||
| Modelia AI visual production tools for fashion brands and retailers. | €1M | Seed | AI · Spain | Rapid Scale, Next Tier Ventures (lead), Archipélago Next, Nacho Rivera | |
| encosa Battery storage planning, financing and operation for commercial and industrial businesses. | €25M | Seed equity and debt facility | Climate tech · Germany | Redstone, WEPA Ventures, Bayern Kapital Innovationsfonds II, Verve Ventures, Kopa Ventures, Heliad, First Momentum Ventures, Blum Ventures, Realyze Ventures (lead), UnternehmerTUM Funding for Innovators | |
| Unastella Develops launch vehicles and engines for small satellite launch services | $24M | Series B | Space tech · South Korea | Altos Ventures, Hana Ventures, Korea Development Bank, Strong Ventures | |
| DriveNets Builds Ethernet-based AI fabric and networking solutions for large-scale AI infrastructure deployments | $410M | Series D | AI · Israel | AMD, Bessemer Venture Partners, Atreides Management, Red Dot Capital, D1 Capital Partners, Pitango | |
| Handshake AI-powered platform for retailers and suppliers to create, track, and execute commercial trade agreements | $3.2M | Seed | Ecommerce · United Kingdom | Octopus Ventures, Future Back Ventures by Bain & Company, Triple Point Ventures | |
| Gradient Labs Develops AI agents to automate customer operations in financial services | $13M | Series A | Fintech · United Kingdom | Octopus Ventures, Redpoint Ventures, Exceptional Capital, CommerzVentures | |
| Veritas Aortic Solutions Develops a non-surgical treatment for Aortic Root and Ascending Aortic Diseases | $12M | Seed | Healthtech · United States | Cedars-Sinai Intellectual Property Company |